Descreva o achado como no laudo. A resposta aponta uma das categorias publicadas, com a probabilidade e o trecho que a decide.
Categorias
Reescritas a partir da fonte e citadas
1
1 de 5
O-RADS MRI 1
Normal ovaries / no adnexal lesion: non-ovarian lesion, or a normal physiologic structure such as a follicle (simple cyst <=3 cm), corpus luteum, or hemorrhagic cyst.
CondutaNo follow-up or additional imaging needed for the ovaries.
verificadoO-RADS MRI risk stratification system for adnexal lesionsPMC9254700, Table 1 'O-RADS MRI scoring system' (Materials and Methods): Score 1 'Normal ovaries' = 'Non-ovarian lesion. Follicle (simple cyst <= 3 cm), corpus luteum, or hemorrhagic cyst'; PPV listed as not applicable. Management per ACR O-RADS MRI committee guideline (Sadowski/Thomassin-Naggara, Radiology 2022, doi 10.1148/radiol.204371; PMID 35040672).
2
2 de 5
O-RADS MRI 2, almost certainly benign
Almost certainly benign lesion: unilocular cyst with simple or endometriotic fluid content, with a smooth enhancing wall and no enhancing solid tissue.
CondutaNo further imaging generally required; managed by the gynecologist as clinically indicated.
RiscoPPV for malignancy < 0.5%.
verificadoO-RADS MRI risk stratification system for adnexal lesionsPMC9254700, Table 1 'O-RADS MRI scoring system': Score 2 (Almost certainly benign) = 'Unilocular cyst with simple or endometrial fluid content (smooth enhancing wall and no enhancing solid tissue)', PPV < 0.5%. Management per ACR O-RADS MRI committee guideline (Radiology 2022, doi 10.1148/radiol.204371; PMID 35040672).
3
3 de 5
O-RADS MRI 3, low risk
Low-risk lesion: unilocular cyst with proteinaceous, hemorrhagic, or mucinous fluid content, with a smooth enhancing wall and no enhancing solid tissue.
CondutaConsider short-interval follow-up (e.g. ultrasound within ~6 months) if not excised; specialist MRI or gynecologist referral as needed for solid components.
RiscoPPV for malignancy approximately 5%.
verificadoO-RADS MRI risk stratification system for adnexal lesionsPMC9254700, Table 1 'O-RADS MRI scoring system': Score 3 (Low risk) = 'Unilocular cyst with proteinaceous, hemorrhagic or mucinous fluid content (smooth enhancing wall and no enhancing solid tissue)', PPV ~ 5%. Management per ACR O-RADS MRI committee guideline (Radiology 2022, doi 10.1148/radiol.204371; PMID 35040672).
4
4 de 5
O-RADS MRI 4, intermediate risk
Intermediate-risk lesion: a lesion containing enhancing solid tissue showing an intermediate-risk (type 2) time-intensity curve on dynamic contrast-enhanced (DCE) MRI.
CondutaGynecologic oncology consultation or referral; evaluation per a gynecologic-oncology protocol given the substantial malignancy risk.
RiscoPPV for malignancy approximately 50%.
verificadoO-RADS MRI risk stratification system for adnexal lesionsPMC9254700, Table 1 'O-RADS MRI scoring system': Score 4 (Intermediate risk) = 'Lesion with solid tissue: intermediate-risk (type 2) time-intensity curve on DCE MRI', PPV ~ 50%. Management per ACR O-RADS MRI committee guideline (Radiology 2022, doi 10.1148/radiol.204371; PMID 35040672).
5
5 de 5
O-RADS MRI 5, high risk
High-risk lesion: a lesion containing enhancing solid tissue showing a high-risk time-intensity curve on dynamic contrast-enhanced (DCE) MRI (or peritoneal/serosal/mesenteric implants).
CondutaDirect gynecologic oncology referral; management per gynecologic-oncology protocol.
RiscoPPV for malignancy approximately 90%.
verificadoO-RADS MRI risk stratification system for adnexal lesionsPMC9254700, Table 1 'O-RADS MRI scoring system': Score 5 (High risk) = 'Lesion with solid tissue: high risk time-intensity curve on DCE MRI', PPV ~ 90%. Management per ACR O-RADS MRI committee guideline (Radiology 2022, doi 10.1148/radiol.204371; PMID 35040672).
Lógica de decisão estruturada
{
"categories": [
"1",
"2",
"3",
"4",
"5"
]
}
Referência, não é dispositivo médico. Confira a publicação primária vigente. O radiologista que assina o laudo continua autor e responsável.